The Open Access Publisher BioMed Central, an information provider with a different approach CLIST 18-04-2005.

The Open Access Publisher

BioMed Central, an information provider with a different approach

CLIST 18-04-2005

What is BioMed Central?

• Independent online publishing house

• Peer-reviewed research

• Covers all areas of medicine and biology

• Immediate, barrier-free open access

• Reverse the traditional business model

BioMed Central The service provider

• Faculty of 1000 – www.facultyof1000.com• images.MD – www.images.md • Genome Biology – http://genomebiology.com• Arthritis Research – http://arthritis-research.com • B C R – http:// breast-cancer-research.com•  Critical Care Forum- http://ccforum.com • C R – www.current-reports.com • C T O – www.treatment-options.com

Agenda

• Traditional publishing model

• BMC Open Access publishing model

• BMC Open Access journals

• Success of BMC journals

• Membership

• Subscription services

Current Publishing model

• Subscription or licence, payable to obtain access

• Authors hand over copyrights to the publisher

PublisherPublisher

Free Use

Manuscript

Today’s (soon yesterday’s) print-derived model:

Only those who can afford expensive subscriptions or

licences have access

Result:

Author transfers copyrightor exclusive publishing rights

©

What’s wrong with it?

• Severe disadvantages of restrictive access

• Political Argument – Pay taxes, have access

• Increasing cost of subscriptions• Increasing number of journals (you can

not have it all!)• Transfer of copyright

To be useful,scientific results need to beused, read, cited, shared,

applied, extended, built-upon

So are they? So are they? So are they? So are they? So are they? So are they? So are they? So are they?

So are they? So are they? So are they? So are they? So are they?

For that, they must be accessible

what we need is:

Unlimiteddissemination

for Optimaluse

OnlyOpen Accessdelivers that!

Open Access publishing modelstherefore deserve the wholehearted support from the science community

What is Open Access?

• The article is universally and freely accessible via the Internet

• The authors retain copyright to their article

• Deposited immediately upon publication, in an internationally recognized open access repository (such as PubMed Central).

How is Open Access achieved at BioMed Central?

• Reversing the business model

• Article processing charge of £450-£835 per published article Waivers are available No colour charges or other ‘hidden’ charges

• Institutional Membership

PublisherPublisherManuscript

Tomorrow’s (today’s at BioMed Central) online-based model:

Everyone has accessAll use is fair use Result:

£450Author pays small amount of money

or rather, institution pays on author’s behalf

OPEN@CCESS

BioMed Central re-defines publishing

Selling content Selling service

Acquiring the rights to content, facilitating peer review, making web-ready, hosting, and embedding in the literature and then selling the content

Leaving the rights with the author, just facilitating peer review, making web-ready, hosting, and embedding in the literature, and making the content freely available

Benefits of publishing in open access journals?

• Free Access =Maximum Visibility

• Higher chances to be cited

• Immediate publication and included in PubMed

• Authors retain copyright

• Substantial save up to institutions and their libraries

• BMC promotes selected articles

Other facts about publishing with BMC

• Peer Review:

all papers are peer reviewed in the ‘traditional’ way

• Secure Archiving:

all articles are permanently archived in PubMed Central, INIST (others to be announced)

• Searchable and retrievable:

all included in PubMed, Scirus, Google, CrossRef, HINARI (some journals are indexed in MEDLINE, Biosis, CAS, an increasing number tracked by ISI for citations)

IndexingPubMed all BMC journals

Medline 45 titles

ISI 18 titles

BIOSIS 24 titles

CAS all BMC journals

Citebase all BMC journals

EMBASE 4 titles

CABI 49 titles

https://www.biomedcentral.com/info/libraries/indexing

BioMed Central’s Journals

• Over 120 open access journals in total in all areas of biology and medicine• Access to all peer-reviewed research content is free

• Highly Selective, general interest: Journal of Biology • Edited by Martin Raff• Free access to outstanding peer-reviewed research in biology

• Selective, high community interest:BMC Medicine and BMC Biology– Publishing peer-reviewed research articles of high quality and broad

interest – Highlighting the best research from the BMC Series

• Sound science, range of interest: – 60 BMC series journals– 60 externally run specialist journals, varying interest and selectivity

Success of BMC journals

General:• Increase of submissions

• 3 fold increase in number of submissions in the past year

Example of experience:• Most successful journal so far: BMC Bioinformatics

• Publishes ~10 articles per month• Rated in top 2 journals in this field by peers• 1 article published in 2002 has 51 citations

Aiming for this achievement in our other journals

Starting a journal with BMC

• How?• Provide a scope statement • Assemble an editorial board – must

demonstrate scientific credibility• Select a journal title• Provide lists of potential authors

• BioMed Central provides a publishing platform, a website and technical expertise for the journals

Examples of new journals published by BioMed Central

BioMed Central’s Membership

• Service offered to institutions to ensure dissemination of research

• Processing charges automatically waived

• 15% discount on BioMed Central’s subscription products

• Customised page on the BMC site

• Annual fee will depend on the total number of graduates, post-graduates, researchers and academics at the institution

There are now almost 400BioMed Central members, including:

– CAUL & CEIRC (Australia) bought 16 licenses– Harvard University – World Health Organization– CNRS, France– Whole State of Ohio– Walter & Eliza Hall Institute of Medical Research– Max Planck Society– University of California (all campuses)– ALL UK Universities– NHS England (Public Hospitals)

There are now over 500BioMed Central members, including:

– Karolinska Institute– Harvard University – CNRS– NIH (National Institute of Health)– OhioLink– Max Planck Society– University of California (all 9 campuses)– ALL UK Universities– NHS England (Public Hospitals)

How can you support open access?

• Add our URL to your intranet or web pages

• Catalogue our journals

• Advocate our model of publishing to other

researchers/scientists

Medical Collection

• Images.MD– Online encyclopaedia of medical images

• Critical Care– Research and review journal

• Current Reports– 21 titles; review journals

• Current Treatment Options– 4 titles; review journals

natashar:

"I think it is now clear that BioMed Central is destined to become one of the dominant online scientific publishers. I feel very strongly that this form of publication represents an important advance in scientific communication. It makes all publications free to anyone that has access to the internet - opening up access to the third world. In addition, it is superior to print journals because there are no space limits, or limits on number or color figures, along with the ability to include detailed lists of data, etc.

I have published six articles in BioMed Central journals in the last two years. I have been very impressed with the high standards and quality of the reviews that I have received. I have had nothing but positive experiences of BioMed Central."

David Levitt, MD, PhD

Professor of Physiology

University of Minnesota

natashar:

"I think it is now clear that BioMed Central is destined to become one of the dominant online scientific publishers. I feel very strongly that this form of publication represents an important advance in scientific communication. It makes all publications free to anyone that has access to the internet - opening up access to the third world. In addition, it is superior to print journals because there are no space limits, or limits on number or color figures, along with the ability to include detailed lists of data, etc.

I have published six articles in BioMed Central journals in the last two years. I have been very impressed with the high standards and quality of the reviews that I have received. I have had nothing but positive experiences of BioMed Central."

David Levitt, MD, PhD

Professor of Physiology

University of Minnesota

Biology Collection

• Faculty of 1000– Scientific literature awareness tool

• Genome Biology– Research and review journal

• Breast Cancer Research– Research and review journal

• Arthritis Research & Therapy– Research and review journal

natashar:

"I think it is now clear that BioMed Central is destined to become one of the dominant online scientific publishers. I feel very strongly that this form of publication represents an important advance in scientific communication. It makes all publications free to anyone that has access to the internet - opening up access to the third world. In addition, it is superior to print journals because there are no space limits, or limits on number or color figures, along with the ability to include detailed lists of data, etc.

I have published six articles in BioMed Central journals in the last two years. I have been very impressed with the high standards and quality of the reviews that I have received. I have had nothing but positive experiences of BioMed Central."

David Levitt, MD, PhD

Professor of Physiology

University of Minnesota

natashar:

"I think it is now clear that BioMed Central is destined to become one of the dominant online scientific publishers. I feel very strongly that this form of publication represents an important advance in scientific communication. It makes all publications free to anyone that has access to the internet - opening up access to the third world. In addition, it is superior to print journals because there are no space limits, or limits on number or color figures, along with the ability to include detailed lists of data, etc.

I have published six articles in BioMed Central journals in the last two years. I have been very impressed with the high standards and quality of the reviews that I have received. I have had nothing but positive experiences of BioMed Central."

David Levitt, MD, PhD

Professor of Physiology

University of Minnesota

Pharmaceutical Collection

• Current Opinion in Drug Discovery & Development

• Current Opinion in Investigational Drugs

• Current Opinion in Molecular Therapeutics

• IDrugs

natashar:

"I think it is now clear that BioMed Central is destined to become one of the dominant online scientific publishers. I feel very strongly that this form of publication represents an important advance in scientific communication. It makes all publications free to anyone that has access to the internet - opening up access to the third world. In addition, it is superior to print journals because there are no space limits, or limits on number or color figures, along with the ability to include detailed lists of data, etc.

I have published six articles in BioMed Central journals in the last two years. I have been very impressed with the high standards and quality of the reviews that I have received. I have had nothing but positive experiences of BioMed Central."

David Levitt, MD, PhD

Professor of Physiology

University of Minnesota

natashar:

"I think it is now clear that BioMed Central is destined to become one of the dominant online scientific publishers. I feel very strongly that this form of publication represents an important advance in scientific communication. It makes all publications free to anyone that has access to the internet - opening up access to the third world. In addition, it is superior to print journals because there are no space limits, or limits on number or color figures, along with the ability to include detailed lists of data, etc.

I have published six articles in BioMed Central journals in the last two years. I have been very impressed with the high standards and quality of the reviews that I have received. I have had nothing but positive experiences of BioMed Central."

David Levitt, MD, PhD

Professor of Physiology

University of Minnesota

Thank you!Marianne Josserand

[email protected]

+44 207 631 9990